Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
923
-
Total 13F shares, excl. options
-
127M
-
Shares change
-
-896K
-
Total reported value, excl. options
-
$27.4B
-
Value change
-
-$328M
-
Put/Call ratio
-
1.01
-
Number of buys
-
376
-
Number of sells
-
-488
-
Price
-
$215.63
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q1 2024
1,126 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q1 2024.
BIOGEN INC. - Common Stock (BIIB) has 923 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 127M shares
of 147M outstanding shares and own 86.42% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (16.6M shares), PRIMECAP MANAGEMENT CO/CA/ (16.2M shares), BlackRock Inc. (14.1M shares), STATE STREET CORP (6.75M shares), T. Rowe Price Investment Management, Inc. (5.17M shares), WELLINGTON MANAGEMENT GROUP LLP (5.12M shares), JPMORGAN CHASE & CO (4.72M shares), GEODE CAPITAL MANAGEMENT, LLC (3.41M shares), VAN ECK ASSOCIATES CORP (1.74M shares), and MORGAN STANLEY (1.7M shares).
This table shows the top 923 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.